Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
Chest
    December 2024
  1. BUSSE WW, Pavord ID, Wechsler ME, Davila IJ, et al
    Stability of Fractional Exhaled Nitric Oxide and its Relationship with Exacerbation in Patients Aged 6 Years or Older with Uncontrolled, Moderate-to-Severe Asthma.
    Chest. 2024 Dec 2:S0012-3692(24)05601-0. doi: 10.1016/j.chest.2024.
    >> Share

    November 2024
  2. MURRAY JK, McNally E, Kent BD
    Clinical accuracy and risk of harm in asthma related content on TikTok.
    Chest. 2024 Nov 9:S0012-3692(24)05466-7. doi: 10.1016/j.chest.2024.
    >> Share

  3. KHALAF Z, Saglani S, Bloom CI
    Implementation and effectiveness of guideline-recommended clinical activities for children with asthma: population-based cohort.
    Chest. 2024 Nov 6:S0012-3692(24)05442-4. doi: 10.1016/j.chest.2024.
    >> Share

  4. CHOTIRMALL SH, Chang AB, Chalmers JD
    Infection vs Inflammation: The Bronchiectasis "Tug Of War".
    Chest. 2024;166:928-930.
    >> Share

  5. ZHUO B, Ran S, Qian AM, Zhang J, et al
    Air Pollution Metabolomic Signatures and Chronic Respiratory Diseases Risk: A Longitudinal Study.
    Chest. 2024;166:975-986.
    >> Share

  6. MATHIOUDAKIS AG, Bate S, Sivapalan P, Jensen JS, et al
    Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial.
    Chest. 2024;166:987-997.
    >> Share

  7. NIU Y, Niu H, Meng X, Zhu Y, et al
    Associations Between Air Pollution and the Onset of Acute Exacerbations of COPD: A Time-Stratified Case-Crossover Study in China.
    Chest. 2024;166:998-1009.
    >> Share

  8. BREMS JH, Vick J, Ashana D, Beach MC, et al
    "Against Medical Advice" Discharges After Respiratory-Related Hospitalizations: Strategies for Respectful Care.
    Chest. 2024;166:1155-1161.
    >> Share

  9. METTLER SK, Nath HP, Grumley S, Orejas JL, et al
    Silent Airway Mucus Plugs in COPD and Clinical Implications.
    Chest. 2024;166:1010-1019.
    >> Share

    October 2024
  10. CHOI H, Hughes C, Eke Z, Shuttleworth M, et al
    Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.
    Chest. 2024 Oct 25:S0012-3692(24)05418-7. doi: 10.1016/j.chest.2024.
    >> Share

  11. POLLOCK J, Goeminne PC, Aliberti S, Polverino E, et al
    Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Chest. 2024 Oct 24:S0012-3692(24)05400-X. doi: 10.1016/j.chest.2024.06.3843.
    >> Share

  12. YANG H, Yang Y, Wang F, Miao C, et al
    Clinical and Prognostic Differences in Mild to Moderate COPD With and Without Emphysema.
    Chest. 2024 Oct 23:S0012-3692(24)05397-2. doi: 10.1016/j.chest.2024.
    >> Share

  13. SHARMA V, Ricketts HC, McCombie L, Brosnahan N, et al
    A one-year weight management programme for difficult-to-treat asthma with obesity: a randomised controlled study.
    Chest. 2024 Oct 18:S0012-3692(24)05320-0. doi: 10.1016/j.chest.2024.
    >> Share

  14. CHALMERS JD, Burgel PR, Daley CL, DE-Soyza A, et al
    TEMPORARY REMOVAL: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BRENSOCATIB IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS - THE ASPEN TRIAL.
    Chest. 2024;166.
    >> Share

  15. JIN Z
    Does Rheumatoid Arthritis Increase the Risk of COPD?
    Chest. 2024;166:e126-e127.
    >> Share

  16. CARR TF
    The Lifelong Burden of Severe Childhood Asthma.
    Chest. 2024;166:653-654.
    >> Share

  17. ROZENBERG D, Reid WD, Camp P, Campos JL, et al
    Translating the Interplay of Cognition and Physical Performance in COPD and Interstitial Lung Disease: Meeting Report and Literature Review.
    Chest. 2024;166:721-732.
    >> Share

  18. QUINTERO SANTOFIMIO V, Knox-Brown B, Potts J, Bartlett-Pestell S, et al
    Small Airways Obstruction and Mortality: Findings From the UK Biobank.
    Chest. 2024;166:712-720.
    >> Share

    September 2024
  19. COUILLARD S, Jackson DJ, Pavord ID, Wechsler ME, et al
    How I do it. Choosing the right biologic for the right patient with severe asthma.
    Chest. 2024 Sep 6:S0012-3692(24)05139-0. doi: 10.1016/j.chest.2024.
    >> Share

    August 2024
  20. COSTANTINI JG, Lo JC, Ko J, Chandra M, et al
    Ethnic Variation in Asthma Prevalence across Childhood in the Asian American and Pacific Islander Population.
    Chest. 2024 Aug 22:S0012-3692(24)04999-7. doi: 10.1016/j.chest.2024.
    >> Share

  21. WANG JM, Araki T, Cottin V, Han MK, et al
    Quantitative imaging methods in combined pulmonary fibrosis and emphysema.
    Chest. 2024 Aug 16:S0012-3692(24)04921-3. doi: 10.1016/j.chest.2024.
    >> Share

  22. RHOADS SL, Mohan A
    A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma.
    Chest. 2024;166:241-242.
    >> Share

  23. BREMS JH, Balasubramanian A, Raju S, Putcha N, et al
    Changes in Spirometry Interpretative Strategies: Implications for Classifying COPD and Predicting Exacerbations.
    Chest. 2024;166:294-303.
    >> Share

    July 2024
  24. PATTI MA, Henderson NB, Phipatanakul W, Jackson-Browne M, et al
    Recommendations for Clinicians to Combat Environmental Disparities in Pediatric Asthma: A Review.
    Chest. 2024 Jul 24:S0012-3692(24)04845-1. doi: 10.1016/j.chest.2024.
    >> Share

  25. VAN GANSE E, Louis R
    International Severe Asthma Registry: Closer to the Full Picture of Asthma Care and Outcomes?
    Chest. 2024;166:3-4.
    >> Share

  26. BOURBEAU J, Sin DD
    Global Initiative for Chronic Obstructive Lung Disease and Canadian Thoracic Society COPD Guidelines: Two Sides of the Same Coin or Different Coins?
    Chest. 2024;166:24-27.
    >> Share

  27. SUISSA S
    COUNTERPOINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? No.
    Chest. 2024;166:17-20.
    >> Share

  28. ADRISH M, Hanania NA
    POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes.
    Chest. 2024;166:12-17.
    >> Share

  29. EKSTROM M, Li PZ, Lewthwaite H, Bourbeau J, et al
    Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation.
    Chest. 2024;166:81-94.
    >> Share

    June 2024
  30. SAVRAN O, Bonnelykke K, Ulrik CS
    Characteristics of adults with severe asthma in childhood - A 60-year Follow-up Study.
    Chest. 2024 Jun 28:S0012-3692(24)00806-7. doi: 10.1016/j.chest.2024.
    >> Share

  31. EWEN R, Pink I, Sutharsan S, Aries SP, et al
    Primary Ciliary Dyskinesia in Adult Bronchiectasis - Data from the German Bronchiectasis Registry PROGNOSIS.
    Chest. 2024 Jun 14:S0012-3692(24)00703-7. doi: 10.1016/j.chest.2024.
    >> Share

  32. SATICI C, Bek EO
    The Role of Electronic Nose Analysis of Exhaled Air in Detection of Lung Cancer Among Patients With COPD.
    Chest. 2024;165:e201.
    >> Share

  33. ROSSIDES M
    Rheumatoid Arthritis and COPD: Thinking Beyond Smoking.
    Chest. 2024;165:1278-1279.
    >> Share

  34. MCDERMOTT GC, Sparks JA
    Rheumatoid Arthritis and Bronchiectasis Risk: Additional Evidence Linking Autoimmunity and Airways Disease.
    Chest. 2024;165:1276-1277.
    >> Share

  35. FARMER MJS, Callahan CD, Hughes AM, Riska KL, et al
    Applying Noninvasive Ventilation in Treatment of Acute Exacerbation of COPD Using Evidence-Based Interprofessional Clinical Practice.
    Chest. 2024;165:1469-1480.
    >> Share

  36. CHUNG C, Kim H, Han K, Jung J, et al
    Does Rheumatoid Arthritis Increase the Risk of COPD?: A Nationwide Retrospective Cohort Study.
    Chest. 2024;165:1362-1371.
    >> Share

  37. KAMINSKA M, Adam V, Orr JE
    Home Noninvasive Ventilation in COPD.
    Chest. 2024;165:1372-1379.
    >> Share

    May 2024
  38. TAN DJ, van Geffen WH, Walters EH
    Impact of Triple Therapy vs Dual Bronchodilator Therapy on Mortality Rates in COPD.
    Chest. 2024;165:e158-e159.
    >> Share

  39. WU WW, Wang G
    How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.
    Chest. 2024;165:e157-e158.
    >> Share

  40. JOHNSON KM, Duan KI
    The Growing Burden of COPD in the United States.
    Chest. 2024;165:1027-1028.
    >> Share

  41. MANNINO DM, Roberts MH, Mapel DW, Zhang Q, et al
    National and Local Direct Medical Cost Burden of COPD in the United States From 2016 to 2019 and Projections Through 2029.
    Chest. 2024;165:1093-1106.
    >> Share

    April 2024
  42. LEE H, Moon JY, Min KH
    Real-World Clinical Studies to Understand the Current Status and Future Improvements of Pulmonary Rehabilitation in Chronic Lung Diseases.
    Chest. 2024;165:e125.
    >> Share

  43. ASH SY
    Quantitative Imaging and Bronchial Thermoplasty: Technically Impressive But Clinically Uncertain.
    Chest. 2024;165:755-756.
    >> Share

  44. SAMANT M, Krings JG, Lew D, Goss CW, et al
    Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders.
    Chest. 2024;165:775-784.
    >> Share

  45. RYU MH, Murphy S, Hinkley M, Carlsten C, et al
    COPD Exposed to Air Pollution: A Path to Understand and Protect a Susceptible Population.
    Chest. 2024;165:836-846.
    >> Share

  46. ARON J, Baldomero AK, Rau A, Fiecas MB, et al
    Individual Risk Factors of PM(2.5) Associated With Wintertime Mortality in Urban Patients With COPD.
    Chest. 2024;165:825-835.
    >> Share

    March 2024
  47. GUPTA S, Couillard S, Digby G, Tse SM, et al
    Climate Change and Inhaler Selection in Patients With Respiratory Disease.
    Chest. 2024;165:503-506.
    >> Share

  48. SAHAY S
    Rebuttal From Dr Sahay.
    Chest. 2024;165:498-499.
    >> Share

  49. BINEY IN, Ari A, Barjaktarevic IZ, Carlin B, et al
    Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium.
    Chest. 2024;165:653-668.
    >> Share

  50. HE D, Yan M, Zhou Y, Ge H, et al
    Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study.
    Chest. 2024;165:573-582.
    >> Share

    February 2024
  51. THOMAS D, McDonald VM, Stevens S, Baraket M, et al
    Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial.
    Chest. 2024 Feb 29:S0012-3692(24)00284-8. doi: 10.1016/j.chest.2024.
    >> Share

  52. LEE TY, Price D, Yadav CP, Roy R, et al
    International variation in severe exacerbation rates in patients with severe asthma.
    Chest. 2024 Feb 21:S0012-3692(24)00264-2. doi: 10.1016/j.chest.2024.
    >> Share

  53. GODET C, Brun AL, Couturaud F, Laurent F, et al
    CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma.
    Chest. 2024 Feb 20:S0012-3692(24)00261-7. doi: 10.1016/j.chest.2024.
    >> Share

  54. WU TD, Diamant Z, Hanania NA
    An Update on Patient-Reported Outcomes in Asthma.
    Chest. 2024 Feb 14:S0012-3692(24)00156-9. doi: 10.1016/j.chest.2024.
    >> Share

  55. CORDEIRO R, Choi H, Haworth CS, Chalmers JD, et al
    The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: Updated systematic review and meta-analysis.
    Chest. 2024 Feb 1:S0012-3692(24)00139-9. doi: 10.1016/j.chest.2024.
    >> Share

  56. MCINTOSH MJ, Hofmann JJ, Kooner HK, Eddy RL, et al
    (129)Xe MRI and Oscillometry of Irritant-Induced Asthma After Bronchial Thermoplasty.
    Chest. 2024;165:e27-e31.
    >> Share

  57. ZAEH SE, Eakin MN, Chupp G
    Implementing Antiinflammatory Reliever Strategies in Asthma: The Evolving Paradigm of Asthma Management.
    Chest. 2024;165:250-252.
    >> Share

  58. MAKRINIOTI H, Bush A
    Can We Test the Function of the Small Airways in Children Outside the Laboratory?
    Chest. 2024;165:241-242.
    >> Share

  59. LEE AL, Burge AT
    Adding Up the Value of Pulmonary Rehabilitation in COPD: Money, Morbidity, and Mortality.
    Chest. 2024;165:231-232.
    >> Share

  60. MAHLER DA, Halpin DMG
    Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD.
    Chest. 2024;165:323-332.
    >> Share

  61. CHOI JY, Kim KU, Kim DK, Kim YI, et al
    Pulmonary Rehabilitation Is Associated With Decreased Exacerbation and Mortality in Patients With COPD: A Nationwide Korean Study.
    Chest. 2024;165:313-322.
    >> Share

    January 2024
  62. CHOI H, Han K, Jung JH, Park J, et al
    Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis.
    Chest. 2024 Jan 4:S0012-3692(24)00002-3. doi: 10.1016/j.chest.2024.
    >> Share

  63. TAJIMA Y, Tashiro T, Furukawa T, Murata K, et al
    Pulmonary Nocardiosis With Endobronchial Involvement Caused by Nocardiaaraoensis.
    Chest. 2024;165:e1-e4.
    >> Share

  64. FARMER MJS, Couillard S, Lastra AC, Ramakrishnan S, et al
    Trailblazing Clinical Trials in Asthma, COPD, Sleep Medicine, and Education and Clinical Practice in 2023.
    Chest. 2024;165:19-21.
    >> Share

  65. KIM T, Kim H, Kong S, Shin SH, et al
    Association Between Regular Moderate to Vigorous Physical Activity Initiation Following COPD Diagnosis and Mortality: An Emulated Target Trial Using Nationwide Cohort Data.
    Chest. 2024;165:84-94.
    >> Share

    December 2023
  66. NAEGER S, Pool V, Macina D
    Increased burden of pertussis among adolescents and adults with asthma or COPD in the US, 2007-2019.
    Chest. 2023 Dec 19:S0012-3692(23)05934-2. doi: 10.1016/j.chest.2023.
    >> Share

  67. KU JH, Henkle E, Carlson KF, Marino M, et al
    Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis.
    Chest. 2023 Dec 10:S0012-3692(23)05846-4. doi: 10.1016/j.chest.2023.
    >> Share

  68. CRISAFULLI E, Sartori G, Huerta A, Gabarrus A, et al
    Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes.
    Chest. 2023;164:1422-1433.
    >> Share

  69. NON AL, Bailey B, Bhatt SP, Casaburi R, et al
    Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes.
    Chest. 2023;164:1492-1504.
    >> Share

    November 2023
  70. HANSEN S, Sondergaard M, von Bulow A, Bjerrum AS, et al
    Clinical response and remission in severe asthma patients treated with biologic therapies.
    Chest. 2023 Nov 2:S0012-3692(23)05695-7. doi: 10.1016/j.chest.2023.
    >> Share

  71. BEASLEY R, Cheng SL, Lee KY, Phuong PT, et al
    ICS/Beta(2)-Agonist Reliever Therapy in Adolescents and Adults With Asthma.
    Chest. 2023;164:1081-1083.
    >> Share

  72. NASSEREDDIN AT, Zayed Y, King RB, Ataya A, et al
    A 28-Year-Old Woman With Nail Discoloration, Recurrent Bronchitis, and Left-Sided Facial Swelling.
    Chest. 2023;164:e135-e138.
    >> Share

  73. BOURBEAU J, Bhutani M, Hernandez P, Aaron SD, et al
    2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Patients With Stable COPD.
    Chest. 2023;164:1159-1183.
    >> Share

  74. LOEBINGER MR, Quint JK, van der Laan R, Obradovic M, et al
    Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis.
    Chest. 2023;164:1115-1124.
    >> Share

  75. MAKIMOTO K, Hogg JC, Bourbeau J, Tan WC, et al
    CT Imaging With Machine Learning for Predicting Progression to COPD in Individuals at Risk.
    Chest. 2023;164:1139-1149.
    >> Share

  76. KIRBY M, Smith BM
    Quantitative CT Scan Imaging of the Airways for Diagnosis and Management of Lung Disease.
    Chest. 2023;164:1150-1158.
    >> Share

    October 2023
  77. LUGOGO NL, Mohan A, Akuthota P, Couillard S, et al
    Are We Ready for Asthma Remission as a Clinical Outcome?
    Chest. 2023;164:831-834.
    >> Share

  78. CHALMERS JD, Shoemark A
    Inhaled Corticosteroids in COPD and Bronchiectasis: Use Biomarkers Rather Than Disease Labels.
    Chest. 2023;164:809-811.
    >> Share

  79. RODRIGUEZ-GARCIA C, Candal-Pedreira C, Perez-Rios M, Ruano-Ravina A, et al
    The Challenge of Diagnosing COPD in Individuals Who Have Never Smoked.
    Chest. 2023;164:835-836.
    >> Share

    September 2023
  80. TZILAS V, Samhouri BF, Hartman TE, Ryu JH, et al
    Unveiling Many Clinicopathologic Entities and Causes Within COPD Using CT Scan.
    Chest. 2023;164:e85-e86.
    >> Share

  81. BALFOUR HH
    Antivirals for COPD?
    Chest. 2023;164:564-565.
    >> Share

  82. POLLOCK J, Goeminne PC
    Eosinophils in Bronchiectasis: A U-Turn for Bronchiectasis Management.
    Chest. 2023;164:561-563.
    >> Share

  83. LINDEN DA, Guo-Parke H, McKelvey MC, Einarsson GG, et al
    Valaciclovir for Epstein-Barr Virus Suppression in Moderate-to-Severe COPD: A Randomized Double-Blind Placebo-Controlled Trial.
    Chest. 2023;164:625-636.
    >> Share

    August 2023
  84. SHTEINBERG M, Sibila O, Stein N, Faner R, et al
    Risk of SARS-CoV-2 infection and disease severity among people with bronchiectasis; analysis of three population registries.
    Chest. 2023 Aug 11:S0012-3692(23)05267-4. doi: 10.1016/j.chest.2023.
    >> Share

  85. MENZIES-GOW AN, Price DB
    Clinical Remission in Severe Asthma: How to Move From Theory to Practice.
    Chest. 2023;164:296-298.
    >> Share

  86. DE-TORRES JP
    "Another Hole in the Wall": The Importance of Centrilobular Emphysema in Patients With COPD.
    Chest. 2023;164:271-272.
    >> Share

  87. VINAY V, Verma P, Kumar A, Modi S, et al
    Pulmonary Cavitation With Eosinophilia in a Young Man.
    Chest. 2023;164:e27-e31.
    >> Share

  88. RAOOF S, Shah M, Braman S, Agrawal A, et al
    Lung Imaging in COPD Part 2: Emerging Concepts.
    Chest. 2023;164:339-354.
    >> Share

  89. ZHU J, Zhou D, Wang J, Yang Y, et al
    A Causal Atlas on Comorbidities in Idiopathic Pulmonary Fibrosis: A Bidirectional Mendelian Randomization Study.
    Chest. 2023;164:429-440.
    >> Share

  90. DEMKOWICZ BJ, Tu SS, Kesselheim AS, Carrier MA, et al
    Patenting Strategies on Inhaler Delivery Devices.
    Chest. 2023;164:450-460.
    >> Share

    July 2023
  91. GOYAL V, Yerkovich ST, Grimwood K, Marchant JM, et al
    Phenotypic features of pediatric bronchiectasis exacerbations associated with symptom resolution after 14-days of oral antibiotic treatment.
    Chest. 2023 Jul 10:S0012-3692(23)00954-6. doi: 10.1016/j.chest.2023.
    >> Share

  92. ROBERTS JM, Goyal V, Kularatna S, Chang AB, et al
    The economic burden of bronchiectasis: a systematic review.
    Chest. 2023 Jul 7:S0012-3692(23)00948-0. doi: 10.1016/j.chest.2023.
    >> Share

  93. PISTENMAA CL, Washko GR
    Chest Imaging of COPD: Bridging the COPD Research Gap With Stop, Look, and Listen.
    Chest. 2023;164:8-10.
    >> Share

  94. FAIN SB, Comellas AP
    Monitoring Biologic Therapy in Asthma Using Functional Imaging.
    Chest. 2023;164:3-5.
    >> Share

  95. RAOOF S, Shah M, Make B, Allaqaband H, et al
    Lung Imaging in COPD Part 1: Clinical Usefulness.
    Chest. 2023;164:69-84.
    >> Share

  96. HARPER LJ, Kidambi P, Kirincich JM, Thornton JD, et al
    Health Disparities: Interventions for Pulmonary Disease - A Narrative Review.
    Chest. 2023;164:179-189.
    >> Share

    June 2023
  97. OPPENHEIMER J, Hanania NA, Chaudhuri R, Sagara H, et al
    Clinic versus home spirometry for monitoring lung function in patients with asthma.
    Chest. 2023 Jun 27:S0012-3692(23)00935-2. doi: 10.1016/j.chest.2023.
    >> Share

  98. RITCHIE AI, Singayagam A, Mitchell S, Wedzicha JA, et al
    The Effect of Inhaled Corticosteroids on Pneumonia Risk in Patients With COPD-Bronchiectasis Overlap: A UK Population-Based Case-Control Study.
    Chest. 2023 Jun 17:S0012-3692(23)00808-5. doi: 10.1016/j.chest.2023.
    >> Share

  99. LI Y, Su C, Yan Y, Wang Z, et al
    A 75-Year-Old Man With Irregular Solid Components Within an Emphysematous Bulla.
    Chest. 2023;163:e265-e273.
    >> Share

  100. YAO X, Barochia AV, Levine SJ
    What's on the Horizon for the Targeted Treatment of Type 2-low Asthma?
    Chest. 2023;163:1362-1364.
    >> Share

  101. COUILLARD S, Cote A
    Predicting On-Biologic Remission in Asthma: Insight From the Airways.
    Chest. 2023;163:1341-1343.
    >> Share

    May 2023
  102. DE VRIES R, Farzan N, Fabius T, De Jongh FHC, et al
    Prospective Detection of Early Lung Cancer in COPD Patients in Regular Care by Electronic Nose Analysis of Exhaled Breath.
    Chest. 2023 May 18:S0012-3692(23)00754-7. doi: 10.1016/j.chest.2023.
    >> Share

  103. JERVAN O, Haukeland-Parker S, Gleditsch J, Tavoly M, et al
    The effects of exercise training in patients with persistent dyspnoea after pulmonary embolism: a randomized controlled trial.
    Chest. 2023 May 4:S0012-3692(23)00643-8. doi: 10.1016/j.chest.2023.
    >> Share

  104. OBA Y
    Data Collection Issues With Mortality Risk of Inhaled Corticosteroids in COPD.
    Chest. 2023;163:e247.
    >> Share

  105. SAHA BK, Wayne MT, Chenna P
    A 52-Year-Old Woman With a History of Ulcerative Colitis and New Onset Severe Dyspnea.
    Chest. 2023;163:e211-e217.
    >> Share

  106. DIVER S, Green RH
    Improving Outcomes in Difficult Asthma: Watch and Weight.
    Chest. 2023;163:999-1000.
    >> Share

  107. TURNBULL CD, Thomas RJ
    Seeking Precision: Endotypes and Phenotypes of OSA.
    Chest. 2023;163:1016-1017.
    >> Share

  108. ROZENBERG D, Maddocks M
    Looking Beyond BMI Classifications With Complementary Assessment of Body Composition in COPD.
    Chest. 2023;163:1003-1004.
    >> Share

  109. VEGAS SANCHEZ-FERRERO G, San Jose Estepar R
    The Value of Virtual Clinical Trials for the Assessment of the Effect of Acquisition Protocols in Emphysema Quantification.
    Chest. 2023;163:1001-1002.
    >> Share

  110. MACHADO FVC, Vogelmeier CF, Jorres RA, Watz H, et al
    Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network.
    Chest. 2023;163:1071-1083.
    >> Share

    April 2023
  111. MARTINEZ-GARCIA MA, Mendez R, Olveira C, Giron R, et al
    The U-shaped relationship between eosinophil count and bronchiectasis severity: the effect of inhaled corticosteroids.
    Chest. 2023 Apr 21:S0012-3692(23)00604-9. doi: 10.1016/j.chest.2023.
    >> Share

  112. ROCHE SM, Carroll TP, Fraughen DD, McElvaney NG, et al
    Alpha-1 Antitrypsin Deficiency and Smoking Cessation: Tackling the Burden of COPD One Test at a Time?
    Chest. 2023;163:e197.
    >> Share

  113. MULPURU S, Aaron SD
    Bronchodilator Responsiveness Over Time: Is This Clinically Meaningful in Tobacco-Exposed Individuals?
    Chest. 2023;163:736-737.
    >> Share

  114. KENDZERSKA T, Gershon AS
    One Size Does Not Fit All: Risk Stratification for COPD Exacerbations.
    Chest. 2023;163:733-735.
    >> Share

  115. BLAGEV DP
    Comparison Among Different Inhalers in COPD: The Differences Are Too Big and Too Small, and It Matters.
    Chest. 2023;163:731-732.
    >> Share

  116. HO JK, Safari A, Adibi A, Sin DD, et al
    Generalizability of Risk Stratification Algorithms for Exacerbations in COPD.
    Chest. 2023;163:790-798.
    >> Share

  117. WENG CF, Wu CC, Wu MH, Lin FJ, et al
    Comparison of Clinical Outcomes Among Different Fixed-Dose Combinations of Long-Acting Muscarinic Antagonists and Long-Acting beta(2)-Agonists in Patients With COPD.
    Chest. 2023;163:799-814.
    >> Share

  118. HERNANDEZ C, Tukpah AC, Mitchell HM, Rosario NA, et al
    Hospital-Level Care at Home for Patients With Acute Respiratory Disease: A Descriptive Analysis.
    Chest. 2023;163:891-901.
    >> Share

    March 2023
  119. YUAN H, Liu Z, Dong J, Bacharier LB, et al
    The fungal microbiome of the upper airway is associated with future loss of asthma control and exacerbation among children with asthma.
    Chest. 2023 Mar 30:S0012-3692(23)00462-2. doi: 10.1016/j.chest.2023.
    >> Share

  120. CHIPPS BE, Israel E, Beasley R, Panettieri RA Jr, et al
    Albuterol-budesonide pressurized metered dose inhaler in patients with mild-to-moderate asthma: results of the DENALI double-blind randomized controlled trial.
    Chest. 2023 Mar 30:S0012-3692(23)00463-4. doi: 10.1016/j.chest.2023.
    >> Share

  121. COSIO BG, Shafiek H, Mosteiro M, Iglesias A, et al
    Redefining the role of bronchoscopy in the work-up of severe uncontrolled asthma in the era of biologics: a prospective study.
    Chest. 2023 Mar 13:S0012-3692(23)00354-9. doi: 10.1016/j.chest.2023.
    >> Share

  122. PEREA L, Faner R, Solarat B, Shoemark A, et al
    Low salivary secretory leukocyte protease inhibitor levels are related to airway Pseudomonas aeruginosa infection in Bronchiectasis.
    Chest. 2023 Mar 8:S0012-3692(23)00318-5. doi: 10.1016/j.chest.2023.
    >> Share

  123. KRISHNAN S, Tan WC, Farias R, Aaron SD, et al
    Impaired spirometry and chronic obstructive pulmonary disease increase the risk of cardiovascular disease: a Canadian cohort study.
    Chest. 2023 Mar 3:S0012-3692(23)00315-X. doi: 10.1016/j.chest.2023.
    >> Share

  124. PALANI P, Lokeshwaran S, Sunil Kumar K, Girish G, et al
    A 33-Year-Old Woman With Breathing Difficulty, Inspiratory Wheeze, and Hemoptysis.
    Chest. 2023;163:e141-e145.
    >> Share

  125. CELLI B
    Screening for COPD: Challenging the United Sates Preventive Services Task Force Recommendation.
    Chest. 2023;163:481-483.
    >> Share

  126. HARRIES TH, Russell REK
    Don't Forget to Look Both Ways: The Role of Blood Eosinophil Counts in Identifying Subgroups and Susceptibility in COPD Patients.
    Chest. 2023;163:467-468.
    >> Share

  127. FORTIS S, Quibrera PM, Comellas AP, Bhatt SP, et al
    Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Chest. 2023;163:502-514.
    >> Share

  128. HUYNH VC, Etruw E, Bok E, Fuhr DP, et al
    Evaluation of an In-Home Virtual Pulmonary Rehabilitation Program for Respiratory Patients Delivered in Response to the COVID Pandemic.
    Chest. 2023;163:529-532.
    >> Share

  129. LEMASTER WB, Quibrera PM, Couper D, Tashkin DP, et al
    Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort.
    Chest. 2023;163:515-528.
    >> Share

  130. FALVO MJ, Sotolongo AM, Osterholzer JJ, Robertson MW, et al
    Consensus Statements on Deployment-Related Respiratory Disease, Inclusive of Constrictive Bronchiolitis: A Modified Delphi Study.
    Chest. 2023;163:599-609.
    >> Share

    February 2023
  131. GRAMEGNA A, Narayana JK, Amati F, Stainer A, et al
    Microbial inflammatory networks in bronchiectasis exacerbators with Pseudomonas aeruginosa.
    Chest. 2023 Feb 16:S0012-3692(23)00259-3. doi: 10.1016/j.chest.2023.
    >> Share

  132. MCINTOSH MJ, Kooner HK, Eddy RL, Wilson A, et al
    CT Mucus Score and 129Xe MRI Ventilation Defects after 2.5-years anti-IL-5Ralpha in Eosinophilic Asthma.
    Chest. 2023 Feb 11:S0012-3692(23)00189-7. doi: 10.1016/j.chest.2023.
    >> Share

  133. MOERMANS C, Brion C, Bock G, Graff S, et al
    Sputum Type 2 markers could predict remission in severe asthma treated with anti-Interleukin-5.
    Chest. 2023 Feb 3:S0012-3692(23)00169-1. doi: 10.1016/j.chest.2023.
    >> Share

  134. RIBLET NBV, Watts BV
    Another Reason to Quit Smoking: Results of a Prospective Study Examining Smoking, COPD, and Suicide.
    Chest. 2023;163:259-261.
    >> Share

  135. ADVIENTO BA, Regan EA, Make BJ, Han MK, et al
    Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals With Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort.
    Chest. 2023;163:292-302.
    >> Share

    January 2023
  136. SHIRAISHI Y, Tanabe N, Shimizu K, Oguma A, et al
    Stronger associations of centrilobular than paraseptal emphysema with longitudinal changes in diffusing capacity and mortality in COPD.
    Chest. 2023 Jan 31:S0012-3692(23)00166-6. doi: 10.1016/j.chest.2023.
    >> Share

  137. SHARMA V, Ricketts HC, McCombie L, Brosnahan N, et al
    A total diet replacement weight management programme for difficult-to-treat asthma associated with obesity: a randomised controlled feasibility trial.
    Chest. 2023 Jan 14:S0012-3692(23)00117-4. doi: 10.1016/j.chest.2023.
    >> Share

  138. DIXON AE, Poynter ME, Garrow OJ, Kaminsky DA, et al
    Peripheral airway dysfunction in obesity and obese asthma.
    Chest. 2023 Jan 4:S0012-3692(23)00005-3. doi: 10.1016/j.chest.2022.
    >> Share

  139. MAJID A, Rosenberg BJ, Ospina Delgado D, Gangadharan S, et al
    Bronchoscopic Lung Volume Reduction After Surgical Fissure Completion Is Not Ready for Prime Time.
    Chest. 2023;163:e48-e49.
    >> Share

  140. MARCINIUK DD, Calzetta L
    Inhaled Corticosteroids and COPD: 25 Years Later and We Are Still Not There.
    Chest. 2023;163:8-9.
    >> Share

  141. WONG C, Martinez-Garcia MA
    Randomized Clinical Trials of Inhaled Antibiotics in Bronchiectasis: Cause for Optimism?
    Chest. 2023;163:3-5.
    >> Share

  142. GARNER O, Hanania NA
    Is Extracorporeal Membrane Oxygenation More Than Just Salvage Therapy in Acute Life-Threatening Asthma?
    Chest. 2023;163:1-2.
    >> Share

  143. CHEN H, Deng ZX, Sun J, Huang Q, et al
    Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials.
    Chest. 2023;163:100-114.
    >> Share

  144. CHOI B, Adan N, Doyle TJ, San Jose Estepar R, et al
    Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts.
    Chest. 2023;163:164-175.
    >> Share

    December 2022
  145. SUISSA S
    Inhaled Corticosteroids and Mortality in COPD: Biases in Randomized Trials.
    Chest. 2022;162:e333-e334.
    >> Share

  146. RAMAKRISHNAN S
    Maintenance Pulmonary Rehabilitation: Can We Keep the Good Times Rolling?
    Chest. 2022;162:1227-1228.
    >> Share

  147. FREI A, Radtke T, Dalla Lana K, Brun P, et al
    Effectiveness of a Long-term Home-Based Exercise Training Program in Patients With COPD After Pulmonary Rehabilitation: A Multicenter Randomized Controlled Trial.
    Chest. 2022;162:1277-1286.
    >> Share

    November 2022
  148. ABADI E, Jadick G, Lynch DA, Segars WP, et al
    Emphysema quantifications with CT: Assessing the effects of acquisition protocols and imaging parameters using virtual imaging trials.
    Chest. 2022 Nov 30:S0012-3692(22)04203-9. doi: 10.1016/j.chest.2022.
    >> Share

  149. ZHANG RL, Pan CX, Tang CL, Cen LJ, et al
    Motile ciliary disorders of the nasal epithelium in adults with bronchiectasis.
    Chest. 2022 Nov 23:S0012-3692(22)04192-7. doi: 10.1016/j.chest.2022.
    >> Share

  150. CAZES N, Briquet A
    COPD Risk After Military Service: Let's Go Further Before Concluding.
    Chest. 2022;162:e287-e288.
    >> Share

  151. SMITH KS, Lee SA, Albers BK, Stevens EL, et al
    A 13-Year-Old Male Patient With Severe Multifocal Pneumonia and Bronchiectasis That Required Extracorporeal Membrane Oxygenation.
    Chest. 2022;162:e265-e271.
    >> Share

  152. KEIR HR, Chalmers JD
    COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No.
    Chest. 2022;162:972-976.
    >> Share

  153. MARTINEZ-GARCIA MA, Alvar Agusti
    POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes.
    Chest. 2022;162:970-972.
    >> Share

  154. CHO EE, Gershon AS
    Single vs Multiple Inhaler Triple Therapy in the COPD Population.
    Chest. 2022;162:947-948.
    >> Share

  155. ALCAZAR-NAVARRETE B, Jamart L, Sanchez-Covisa J, Juarez M, et al
    Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
    Chest. 2022;162:1017-1029.
    >> Share

  156. NEDER JA, Kirby M, Santyr G, Pourafkari M, et al
    V/Q Mismatch: A Novel Target for COPD Treatment.
    Chest. 2022;162:1030-1047.
    >> Share

    October 2022
  157. MAKRINIOTI H, Camargo CA Jr, Jartti T, Hasegawa K, et al
    Toward Precision Epidemiology in Bronchiolitis.
    Chest. 2022;162:744-746.
    >> Share

  158. TRUPIN L, Schmajuk G, Ying D, Yelin E, et al
    Military Service and COPD Risk.
    Chest. 2022;162:792-795.
    >> Share

    September 2022
  159. ZAKRAJSEK JK, Min SJ, Ho PM, Kiser TH, et al
    Extracorporeal Membrane Oxygenation (ECMO) for Refractory Asthma Exacerbations with Respiratory Failure.
    Chest. 2022 Sep 30. pii: S0012-3692(22)03899-5. doi: 10.1016/j.chest.2022.
    >> Share

  160. KHASAWNEH M, Leon ME, Urbine D
    A 65-Year-Old Woman With Intractable Cough.
    Chest. 2022;162:e123-e126.
    >> Share

  161. SODHI A, Pisani M, Glassberg MK, Bourjeily G, et al
    Sex and Gender in Lung Disease and Sleep Disorders: A State-of-the-Art Review.
    Chest. 2022;162:647-658.
    >> Share

  162. DIAZ DEL VALLE F, Zakrajsek JK, Min SJ, Koff PB, et al
    Impact of Airline Secondhand Tobacco Smoke Exposure on Respiratory Health and Lung Function Decades After Exposure Cessation.
    Chest. 2022;162:556-568.
    >> Share

    August 2022
  163. VICENDESE D, Yerkovich S, Grimwood K, Valery PC, et al
    Long-term azithromycin in children with bronchiectasis unrelated to cystic fibrosis: treatment effects over time.
    Chest. 2022 Aug 25. pii: S0012-3692(22)03684.
    >> Share

  164. SHAFIQ M, Polhemus E, Perkins R, Forth V, et al
    Bilateral Bronchoscopic Lung Volume Reduction After Surgical Fissure Completion.
    Chest. 2022;162:e73-e75.
    >> Share

  165. ATWOOD CE, Bhutani M, Ospina MB, Rowe BH, et al
    Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator: A Randomized Clinical Trial.
    Chest. 2022;162:321-330.
    >> Share

    July 2022
  166. GUAN WJ, Xu JF, Luo H, Xu XX, et al
    A Double-blind Randomized Placebo-controlled Phase-3 Trial of Tobramycin Inhalation Solution in Adults with Bronchiectasis with Pseudomonas aeruginosa Infection.
    Chest. 2022 Jul 18. pii: S0012-3692(22)01247-8. doi: 10.1016/j.chest.2022.
    >> Share

  167. MORRIS TA, Fernandes TM, Channick R
    How we do it: evaluation of dyspnea and exercise intolerance after acute pulmonary embolism.
    Chest. 2022 Jul 2. pii: S0012-3692(22)01215-6. doi: 10.1016/j.chest.2022.
    >> Share

  168. HAHN DL
    Azithromycin Response in Uncontrolled Asthma in Children: Binary or Continuous?
    Chest. 2022;162:e61.
    >> Share

  169. LUGOGO N, Mohan A
    Are We Poised to Change the Trajectory of Maintenance Oral Corticosteroid Use in Severe Asthma in the Age of Biologics?
    Chest. 2022;162:4-5.
    >> Share

  170. THOMAS D, Gibson PG
    Long-Term, Low-Dose Azithromycin for Uncontrolled Asthma in Children.
    Chest. 2022;162:27-29.
    >> Share

  171. SPRUIT MA, Tan WC
    Physical Frailty Makes Matters Worse in People With COPD.
    Chest. 2022;162:25-26.
    >> Share

  172. GUERRA S
    Nonobstructive Chronic Bronchitis: A Sentinel for Risk of Premature Death in Smokers?
    Chest. 2022;162:19-21.
    >> Share

  173. KANJ AN, Ryu JH
    Severe Airflow Obstruction From Constrictive (Obliterative) Bronchiolitis in Paraneoplastic Autoimmune Multiorgan Syndrome.
    Chest. 2022;162:179-183.
    >> Share

  174. FORTIS S, Shannon ZK, Garcia CJ, Guillamet RV, et al
    Association of Nonobstructive Chronic Bronchitis With All-Cause Mortality: A Systematic Literature Review and Meta-analysis.
    Chest. 2022;162:92-100.
    >> Share

  175. CHERIAN SV, Patel D, Machnicki S, Naidich D, et al
    Algorithmic Approach to the Diagnosis of Organizing Pneumonia: A Correlation of Clinical, Radiologic, and Pathologic Features.
    Chest. 2022;162:156-178.
    >> Share

  176. HUG S, Cavalheri V, Gucciardi DF, Hill K, et al
    An Evaluation of Factors That Influence Referral to Pulmonary Rehabilitation Programs Among People With COPD.
    Chest. 2022;162:82-91.
    >> Share

    June 2022
  177. VAES AW, Spruit MA, Koolen EH, Antons JC, et al
    "Can Do, Do Do" Quadrants and 6-Year All-Cause Mortality in Patients With COPD.
    Chest. 2022;161:1494-1504.
    >> Share

    May 2022
  178. SINGH J, Randev S, Kumar P, Mahajan V, et al
    A 16-Year-Old-Girl With Asthma, Palpable Purpura, and Hypereosinophilia.
    Chest. 2022;161:e305-e308.
    >> Share

  179. HUDLER AC, Sharma S
    Understanding the Genetics of Asthma-COPD Overlap.
    Chest. 2022;161:1125-1126.
    >> Share

  180. LEE SY, Nyunt MSZ, Gao Q, Gwee X, et al
    Co-occurrence of Physical Frailty and COPD and Association With Disability and Mortality: Singapore Longitudinal Ageing Study.
    Chest. 2022;161:1225-1238.
    >> Share

  181. ESTHER CR JR, O'Neal WK, Anderson WH, Kesimer M, et al
    Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.
    Chest. 2022;161:1239-1249.
    >> Share

  182. IYER AS, Sullivan DR, Lindell KO, Reinke LF, et al
    The Role of Palliative Care in COPD.
    Chest. 2022;161:1250-1262.
    >> Share

    April 2022
  183. CLARK SM, Parker AM, Ataya A
    A 31-Year-Old Man With Asthma, Chest Discomfort, and Shortness of Breath.
    Chest. 2022;161:e209-e212.
    >> Share

  184. PAUL TK, Kim JS
    Can Interstitial Lung Abnormalities Explain a High FVC in a Smoker With Emphysema?
    Chest. 2022;161:872-873.
    >> Share

  185. YAWN BP
    Developing and Disseminating Evidence to Support Enhanced Spirometry Use in Primary Care Diagnosis of Asthma and COPD.
    Chest. 2022;161:865-866.
    >> Share

  186. POULOSE V
    Classification of Small Airways.
    Chest. 2022;161:e249.
    >> Share

  187. MASON SE, Moreta-Martinez R, Labaki WW, Strand MJ, et al
    Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers.
    Chest. 2022;161:960-970.
    >> Share

  188. YEE N, Markovic D, Buhr RG, Fortis S, et al
    Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.
    Chest. 2022;161:949-959.
    >> Share

    March 2022
  189. MCINTOSH MJ, Kooner HK, Eddy RL, Jeimy S, et al
    Asthma control, Airway mucus and (129)Xe MRI ventilation after a single Benralizumab dose.
    Chest. 2022 Mar 10. pii: S0012-3692(22)00424-X. doi: 10.1016/j.chest.2022.
    >> Share

  190. MOSS MH, Lugogo NL, Castro M, Hanania NA, et al
    Results of a phase 2b trial with GB001, a DP2 antagonist, in moderate-to-severe eosinophilic asthma.
    Chest. 2022 Mar 3. pii: S0012-3692(22)00405-6. doi: 10.1016/j.chest.2022.
    >> Share


  191. Correction to Figure in: Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
    Chest. 2022;161:863.
    >> Share

  192. NOLAN CM, Polgar O, Schofield SJ, Patel S, et al
    Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and COPD: A Propensity-Matched Real-World Study.
    Chest. 2022;161:728-737.
    >> Share

  193. WAN ES, Hokanson JE, Regan EA, Young KA, et al
    Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
    Chest. 2022;161:651-661.
    >> Share

  194. WOUTERS EFM, Breyer-Kohansal R
    Spirometry: The Indefinite Search for Gold.
    Chest. 2022;161:593-594.
    >> Share

  195. ROSE EK, O'Connor J
    Addressing Advance Care Planning in Patients With COPD.
    Chest. 2022;161:676-683.
    >> Share

  196. SYED N, Ryu MH, Dhillon S, Schaeffer MR, et al
    Effects of Traffic-Related Air Pollution on Exercise Endurance, Dyspnea, and Cardiorespiratory Responses in Health and COPD: A Randomized, Placebo-Controlled, Crossover Trial.
    Chest. 2022;161:662-675.
    >> Share

    February 2022
  197. GARNER O, Ramey JS, Hanania NA
    Management of Life-Threatening Asthma: Severe Asthma Series.
    Chest. 2022 Feb 23. pii: S0012-3692(22)00395-6. doi: 10.1016/j.chest.2022.
    >> Share

  198. SHER LD, Wechsler ME, Rabe KF, Maspero JF, et al
    Dupilumab reduces oral corticosteroid use in patients with corticosteroid-dependent severe asthma: An analysis of the phase 3, open-label extension TRAVERSE trial.
    Chest. 2022 Feb 22. pii: S0012-3692(22)00388-9. doi: 10.1016/j.chest.2022.
    >> Share

  199. GHIMIRE JJ, Jat KR, Sankar J, Lodha R, et al
    Azithromycin for Poorly Controlled Asthma in Children: A randomized controlled trial.
    Chest. 2022 Feb 21. pii: S0012-3692(22)00293-8. doi: 10.1016/j.chest.2022.
    >> Share

  200. VAMEGHESTAHBANATI M, Hiura GT, Barr RG, Sieren JC, et al
    CT-Assessed Dysanapsis and Airflow Obstruction in Early and Mid Adulthood.
    Chest. 2022;161:389-391.
    >> Share

    January 2022
  201. JOHN C, Guyatt AL, Shrine N, Packer R, et al
    Genetic associations and architecture of asthma-chronic obstructive pulmonary disease overlap.
    Chest. 2022 Jan 29. pii: S0012-3692(22)00198-2. doi: 10.1016/j.chest.2021.
    >> Share

  202. KOVACS G, Avian A, Bachmaier G, Troester N, et al
    Severe pulmonary hypertension in COPD - impact on survival and diagnostic approach.
    Chest. 2022 Jan 26. pii: S0012-3692(22)00192-1. doi: 10.1016/j.chest.2022.
    >> Share

  203. SURI R, Macinko J, Inkelas M, Needleman J, et al
    The relationship between insurance status and the Affordable Care Act on asthma outcomes among low-income US adults.
    Chest. 2022 Jan 15. pii: S0012-3692(22)00046-0. doi: 10.1016/j.chest.2022.
    >> Share

  204. CHIAPPETTA M, Sassorossi C, Lococo F, Lorusso R, et al
    Intrapleural Foreign Body in a Critically Ill Patient: What Can We Do?
    Chest. 2022;161:e51-e53.
    >> Share

  205. MAJUMDAR U, Hatipoglu U, Stoller JK
    A 21-Year-Old Man With Dyspnea, Wheezing, and Cough.
    Chest. 2022;161:e13-e17.
    >> Share

    December 2021
  206. AZAM MB, Chhabra S, Agrawal S, Sharma P, et al
    A 37-Year-Old Man With Bronchial Asthma and Unexplained Hypoxemia.
    Chest. 2021;160:e633-e638.
    >> Share

  207. HILL K, Dolmage TE
    Take a Deep Breath: More Support for Noninvasive Ventilation During Exercise in People With COPD.
    Chest. 2021;160:1991-1992.
    >> Share

  208. DENNIS CJ, Menadue C, Schneeberger T, Leitl D, et al
    Bilevel Noninvasive Ventilation During Exercise Reduces Dynamic Hyperinflation and Improves Cycle Endurance Time in Severe to Very Severe COPD.
    Chest. 2021;160:2066-2079.
    >> Share

  209. BURTIN C, Mohan D, Troosters T, Watz H, et al
    Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.
    Chest. 2021;160:2080-2100.
    >> Share

    November 2021
  210. PINSKY PF, Lynch DA, Gierada DS
    Incidental Findings on Low-Dose CT Lung Cancer Screenings and Deaths from Respiratory Diseases.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04413-5. doi: 10.1016/j.chest.2021.
    >> Share

  211. HULL RC, Huang JT, Barton AK, Keir HR, et al
    Sputum Proteomics in non-Tuberculous Mycobacterial Lung Disease.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04412-3. doi: 10.1016/j.chest.2021.
    >> Share

  212. CHUPP G, Kline JN, Khatri SB, McEvoy C, et al
    Bronchial Thermoplasty in Severe Asthmatics At 5 Years: The PAS2 Study.
    Chest. 2021 Nov 10. pii: S0012-3692(21)04274-4. doi: 10.1016/j.chest.2021.
    >> Share

  213. MENON AA, Putman RK, Sanders JL, Hino T, et al
    Interstitial Lung Abnormalities, Emphysema and Spirometry in Smokers.
    Chest. 2021 Nov 3. pii: S0012-3692(21)04260-4. doi: 10.1016/j.chest.2021.
    >> Share

  214. YAMADA J, Shin Cheung JL, Gagne M, Spiegel-Feld C, et al
    Barriers and Enablers to Objective Testing for Asthma and COPD in Primary Care: A Systematic Review Using the Theoretical Domains Framework.
    Chest. 2021 Nov 2. pii: S0012-3692(21)04256-2. doi: 10.1016/j.chest.2021.
    >> Share

  215. BARN P, Rideout KL, Lo W, Josey D, et al
    Better together: Launching and nurturing a Community Stakeholder Committee to enhance care and research for asthma and COPD.
    Chest. 2021 Nov 2. pii: S0012-3692(21)04254-9. doi: 10.1016/j.chest.2021.
    >> Share

  216. GOEL K, Maleki-Fischbach M, George MP, Kim D, et al
    A 56-Year-Old Man With Emphysema, Rash, and Arthralgia.
    Chest. 2021;160:e513-e518.
    >> Share

  217. OKEREKE J, Malin M, Koo P
    A 31-Year-Old Pregnant Woman With Asthma, Presenting With Worsening Dyspnea, Wheeze, and Hoarseness.
    Chest. 2021;160:e507-e512.
    >> Share


  218. Correction to Funding/Support in: International Severe Asthma Registry: Mission Statement.
    Chest. 2021;160:1989.
    >> Share


  219. Correction to Funding/Support in: Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry.
    Chest. 2021;160:1989.
    >> Share

  220. GAURAV R, Anderson DR, Radio SJ, Bailey KL, et al
    IL-33 Depletion in COVID-19 Lungs.
    Chest. 2021;160:1656-1659.
    >> Share

  221. LAHOUSSE L
    Personalizing Oral Corticosteroid Dose in Severe COPD Exacerbations.
    Chest. 2021;160:1581-1582.
    >> Share

  222. HILL NS, Criner GJ, Branson RD, Celli BR, et al
    Optimal NIV Medicare Access Promotion: Patients With COPD: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic
    Chest. 2021;160:e389-e397.
    >> Share

  223. GERSHON AS, Pequeno P, Alberga Machado A, Aaron SD, et al
    Factors Associated With Nonreceipt of Recommended COPD Medications: A Population Study.
    Chest. 2021;160:1670-1680.
    >> Share

  224. LI L, Zhao N, Ma X, Sun F, et al
    Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbations of COPD: A Prospective, Multicenter, Randomized, Open-Label Clinical Trial.
    Chest. 2021;160:1660-1669.
    >> Share

    October 2021
  225. SAFIRI S, Carson-Chahhoud K, Karamzad N, Sullman MJM, et al
    Prevalence, deaths and disability-adjusted-life-years (DALYs) due to asthma and its attributable risk factors in 204 countries and territories, 1990-2019.
    Chest. 2021 Oct 23. pii: S0012-3692(21)04206-9. doi: 10.1016/j.chest.2021.
    >> Share

  226. RUPANI H, Kent BD
    Using FeNO Measurement in Clinical Asthma Management.
    Chest. 2021 Oct 18. pii: S0012-3692(21)04109-X. doi: 10.1016/j.chest.2021.
    >> Share

  227. MENDEZ R, Feced L, Alcaraz-Serrano V, Gonzalez-Jimenez P, et al
    Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.
    Chest. 2021 Oct 14. pii: S0012-3692(21)04101-5. doi: 10.1016/j.chest.2021.
    >> Share

  228. LEUNG C, Sin DD
    Asthma-COPD Overlap: What are the important questions?
    Chest. 2021 Oct 6. pii: S0012-3692(21)04078-2. doi: 10.1016/j.chest.2021.
    >> Share

  229. ZAFAR MA, Sengupta R, Bates A, Woods JC, et al
    Oral Positive Expiratory Pressure Device for Excessive Dynamic Airway Collapse Caused by Emphysema.
    Chest. 2021;160:e333-e337.
    >> Share

  230. BERTELS X, Lahousse L
    Benefits of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers on Progression of Emphysema and Lung Function Decline.
    Chest. 2021;160:1160-1162.
    >> Share

  231. KANTAR A
    Bronchiectasis in Australian First Nations Children: Looking Inside the Gunyah.
    Chest. 2021;160:1153-1154.
    >> Share

  232. AKUTHOTA P, Jackson DJ, Wechsler ME
    Introducing the Severe Asthma Series of Invited Reviews.
    Chest. 2021;160:1151-1152.
    >> Share

  233. MARCIANO BE, Olivier KN, Folio LR, Zerbe CS, et al
    Pulmonary Manifestations of GATA2 Deficiency.
    Chest. 2021;160:1350-1359.
    >> Share

  234. WANG MT, Lai JH, Huang YL, Liou JT, et al
    Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting beta2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting beta2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity S
    Chest. 2021;160:1255-1270.
    >> Share

  235. GLASSBERG MK, Csete I, Simonet E, Elliot SJ, et al
    Stem Cell Therapy for COPD: Hope and Exploitation.
    Chest. 2021;160:1271-1281.
    >> Share

    September 2021
  236. ZOU RH, Bon J
    Reduced Dlco in GOLD I COPD: Moving Towards a Multidimensional Approach to Risk Stratification.
    Chest. 2021;160:791-792.
    >> Share

  237. YOSHIDA M, Miyahara Y, Orimo K, Kono N, et al
    Eosinophil Extracellular Traps in the Casts of Plastic Bronchitis Associated With Influenza Virus Infection.
    Chest. 2021;160:854-857.
    >> Share

  238. DE-TORRES JP, O'Donnell DE, Marin JM, Cabrera C, et al
    Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD.
    Chest. 2021;160:872-878.
    >> Share

  239. WU TD, Fawzy A, Brigham E, McCormack MC, et al
    Association of Triglyceride-Glucose Index and Lung Health: A Population-Based Study.
    Chest. 2021;160:1026-1034.
    >> Share

    August 2021
  240. HEIDORN MW, Steck S, Muller F, Trobs SO, et al
    Forced expiratory volume in one second predicts cardiac status and outcome in chronic heart failure.
    Chest. 2021 Aug 17. pii: S0012-3692(21)03682.
    >> Share

  241. TATAH J, Keen JL, Prisco SZ, Pritzker M, et al
    Iron Deficiency is Associated with More Severe Pulmonary Vascular Disease in Pulmonary Hypertension due to Chronic Lung Disease.
    Chest. 2021 Aug 2. pii: S0012-3692(21)03610-2. doi: 10.1016/j.chest.2021.07.2159
    >> Share

  242. KLINGER JR
    Treatment of Pulmonary Hypertension Associated With COPD: Time for Another Look?
    Chest. 2021;160:409-410.
    >> Share

  243. DECATO TW, Hegewald MJ
    Diffusing Capacity, the Too Often Ignored Lung Function Test in COPD.
    Chest. 2021;160:389-390.
    >> Share

  244. SOLED DR, Thurber E, Amundson B, Schissel SL, et al
    Payment Reform as a Means of Achieving Justice: A Look at Pulmonary Rehabilitation Reimbursement.
    Chest. 2021;160:786-788.
    >> Share

  245. CASANOVA C, Gonzalez-Davila E, Martinez-Gonzalez C, Cosio BG, et al
    Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex.
    Chest. 2021;160:481-490.
    >> Share

  246. MAHLER DA, Halpin DMG
    Peak Inspiratory Flow as a Predictive Therapeutic Biomarker in COPD.
    Chest. 2021;160:491-498.
    >> Share

    July 2021
  247. CHONG WH, Saha B, Ibrahim A, Smith TC, et al
    Dyspnea in a 57-Year-Old Man With Recent Viral Illness.
    Chest. 2021;160:e19-e24.
    >> Share

  248. PISTELLI F, Carrozzi L
    Slow Is Better Than Fast?: Usefulness of FEV1/Slow Vital Capacity <0.7 in the Identification of Asymptomatic Ever Smokers at Risk for COPD.
    Chest. 2021;160:7-8.
    >> Share

  249. DEMEO DL
    Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.
    Chest. 2021;160:104-113.
    >> Share

  250. FORTIS S, Comellas AP, Bhatt SP, Hoffman EA, et al
    Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
    Chest. 2021;160:94-103.
    >> Share

    June 2021
  251. BUTLER SJ, Gershon AS, Goodridge DM
    Perspectives on Palliative Care in COPD.
    Chest. 2021;159:2133-2134.
    >> Share

  252. DIVO M
    Increased Health Care Use: With or From COPD?
    Chest. 2021;159:2131-2132.
    >> Share

  253. SHEN E, Lee JS, Mularski RA, Crawford P, et al
    COPD Comorbidity Profiles and 2-Year Trajectory of Acute and Postacute Care Use.
    Chest. 2021;159:2233-2243.
    >> Share

  254. SERBAN KA, Pratte KA, Bowler RP
    Protein Biomarkers for COPD Outcomes.
    Chest. 2021;159:2244-2253.
    >> Share

  255. FU Y, Mason A, Boland AC, Linklater G, et al
    Palliative Care Needs and Integration of Palliative Care Support in COPD: A Qualitative Study.
    Chest. 2021;159:2222-2232.
    >> Share

  256. GAFFNEY AW, Hawks L, Bor D, White AC, et al
    National Trends and Disparities in Health Care Access and Coverage Among Adults With Asthma and COPD: 1997-2018.
    Chest. 2021;159:2173-2182.
    >> Share

    May 2021
  257. CHANDRA D, Gupta A, Kinney GL, Fuhrman CR, et al
    The Association between Lung Hyperinflation and Coronary Artery Disease in Smokers.
    Chest. 2021 May 7. pii: S0012-3692(21)00889-8. doi: 10.1016/j.chest.2021.
    >> Share

  258. CHONG WH, Saha B, Shkolnik B
    Persistent Dyspnea in a 74-Year-Old Man With Normal Spirometry and Lung Volumes.
    Chest. 2021;159:e303-e307.
    >> Share

  259. HAZELETT BN, Paton A, Majid A, Schreefer K, et al
    Nurse Coordinator Roles and Responsibilities for Bronchoscopic Lung Volume Reduction With Endobronchial Valves.
    Chest. 2021;159:2090-2098.
    >> Share

  260. NYBERG A, Martin M, Saey D, Milad N, et al
    Effects of Low-Load/High-Repetition Resistance Training on Exercise Capacity, Health Status, and Limb Muscle Adaptation in Patients With Severe COPD: A Randomized Controlled Trial.
    Chest. 2021;159:1821-1832.
    >> Share

    April 2021
  261. DAY K, Ostridge K, Conway J, Cellura D, et al
    Interrelationships Among Small Airways Dysfunction, Neutrophilic Inflammation, and Exacerbation Frequency in COPD.
    Chest. 2021;159:1391-1399.
    >> Share

  262. SAEED GJ, Valero-Elizondo J, Mszar R, Grandhi GR, et al
    Prevalence and Disparities in Influenza Vaccination Among Patients With COPD in the United States.
    Chest. 2021;159:1411-1414.
    >> Share

  263. ZAFARI Z, Li S, Eakin MN, Bellanger M, et al
    Projecting Long-term Health and Economic Burden of COPD in the United States.
    Chest. 2021;159:1400-1410.
    >> Share

    February 2021
  264. VIZZA CD, Hoeper MM, Huscher D, Pittrow D, et al
    Pulmonary hypertension in patients with chronic obstructive lung disease: results from COMPERA.
    Chest. 2021 Feb 10. pii: S0012-3692(21)00272-5. doi: 10.1016/j.chest.2021.
    >> Share

    November 2020
  265. YOUNG RP, Hopkins RJ, Gamble GD, Silvestri GA, et al
    Incorporating baseline lung function in lung cancer screening: Does a "lung health check" help predict outcomes?
    Chest. 2020 Nov 7. pii: S0012-3692(20)35129-1. doi: 10.1016/j.chest.2020.
    >> Share

    August 2020
  266. KAVANAGH JE, Hearn AP, Dhariwal J, Grainne d'Ancona, et al
    Real World Effectiveness of Benralizumab in Severe Eosinophilic Asthma.
    Chest. 2020 Aug 31. pii: S0012-3692(20)34313.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016